Lumos Pharma, Inc. (LUMO)
USD 4.34
(0.0%)
USD 4.34
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 2.05 Million | 1.52 Million | 230 Thousand | 168 Thousand | 936 Thousand | 1.2 Million |
| Cost of Revenue | 44 Thousand | 49 Thousand | - | - | 37 Thousand | -11.26 Million |
| Gross Profit | 2 Million | 1.47 Million | 230 Thousand | 168 Thousand | 899 Thousand | 12.47 Million |
| Operating Expenses | 38.66 Million | 33.56 Million | 31.57 Million | 26.47 Million | 46.07 Million | 63.64 Million |
| Selling, General and Administrative Expenses | 16.56 Million | 15.7 Million | 15.33 Million | 17.26 Million | 23.86 Million | 29.21 Million |
| Research and Development Expenses | 22.09 Million | 17.85 Million | 16.24 Million | 9.2 Million | 22.2 Million | 45.69 Million |
| Other Expenses | - | 91 Thousand | 269 Thousand | 6.46 Million | -19 Thousand | -102 Thousand |
| Cost and Expenses | 38.66 Million | 33.56 Million | 31.57 Million | 26.47 Million | 46.07 Million | 63.64 Million |
| Operating Income | -36.61 Million | -32.04 Million | -31.34 Million | -26.3 Million | -45.13 Million | -62.43 Million |
| Interest Expense | - | 874 Thousand | - | - | 50 Thousand | 52 Thousand |
| Income Tax Expense | -29 Thousand | -13 Thousand | -636 Thousand | -13.97 Million | 12 Thousand | -6.96 Million |
| Earnings before Tax | -34.06 Million | -31.07 Million | -31.06 Million | -19.63 Million | -42.97 Million | -60.56 Million |
| Net Income | -34.03 Million | -31.06 Million | -30.43 Million | -5.66 Million | -42.98 Million | -53.59 Million |
| Earnings Per Share Basic | -4.18 | -3.71 | -3.65 | -0.84 | -297.07 | -12.97 |
| Earnings Per Share Diluted | -4.18 | -3.71 | -3.65 | -0.84 | -297.07 | -12.97 |
| Weighted Average Shares Outstanding | 8.14 Million | 8.37 Million | 8.33 Million | 6.77 Million | 144.7 Thousand | 4.13 Million |
| Weighted Average Shares Outstanding (Diluted) | 8.14 Million | 8.37 Million | 8.33 Million | 6.77 Million | 144.7 Thousand | 4.13 Million |
| Gross Margin | 0.98 | 0.97 | 1.00 | 1.00 | 0.96 | 10.34 |
| EBIT Margin | -17.83 | -21.04 | -136.29 | -156.57 | -45.86 | -50.17 |
| Profit Margin | -16.59 | -20.40 | -132.30 | -33.71 | -45.93 | -44.44 |
| EBITDA | -36.57 Million | -31.99 Million | -31.13 Million | -25.71 Million | -45.13 Million | -59.36 Million |
| Earnings Before Tax Margin | -17.85 | -21.04 | -136.29 | -156.57 | -48.22 | -51.77 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 488 Thousand | 165 Thousand | 826 Thousand | 2.05 Million | 7000.00 | 527 Thousand |
| Cost of Revenue | 2000.00 | 2000.00 | 18 Thousand | 44 Thousand | 8000.00 | 9000.00 |
| Gross Profit | 486 Thousand | 163 Thousand | 808 Thousand | 2 Million | -1000.00 | 518 Thousand |
| Operating Expenses | 8.3 Million | 11.02 Million | 10.81 Million | 38.62 Million | 8.93 Million | 10.17 Million |
| Selling, General and Administrative Expenses | 3.68 Million | 3.77 Million | 4.15 Million | - | 3.89 Million | 4.14 Million |
| Research and Development Expenses | 4.62 Million | 7.24 Million | 6.65 Million | - | 5.04 Million | 6.02 Million |
| Other Expenses | 202 Thousand | 263 Thousand | 254 Thousand | 683 Thousand | 186 Thousand | 124 Thousand |
| Cost and Expenses | 8.31 Million | 11.02 Million | 10.83 Million | 38.66 Million | 8.93 Million | 10.17 Million |
| Operating Income | -7.82 Million | -10.86 Million | -10 Million | -36.61 Million | -8.93 Million | -9.64 Million |
| Interest Expense | - | - | 689 Thousand | - | - | - |
| Income Tax Expense | - | -41.27 Thousand | 726 Thousand | -29 Thousand | -8000.00 | -29 Thousand |
| Earnings before Tax | -7.55 Million | -10.44 Million | -9.45 Million | -34.06 Million | -8.3 Million | -8.96 Million |
| Net Income | -7.55 Million | -10.44 Million | -9.45 Million | -34.03 Million | -8.3 Million | -8.93 Million |
| Earnings Per Share Basic | -0.93 | -1.29 | -1.17 | - | -1.04 | -1.09 |
| Earnings Per Share Diluted | -0.93 | -1.29 | -1.17 | - | -1.04 | -1.09 |
| Weighted Average Shares Outstanding | 8.11 Million | 8.1 Million | 8.1 Million | 8.14 Million | 7.97 Million | 8.16 Million |
| Weighted Average Shares Outstanding (Diluted) | 8.11 Million | 8.1 Million | 8.1 Million | 8.14 Million | 7.97 Million | 8.16 Million |
| Gross Margin | 1.00 | 0.99 | 0.98 | 0.98 | -0.14 | 0.98 |
| EBIT Margin | -16.03 | -65.82 | -12.09 | - | -1276.00 | -18.30 |
| Profit Margin | -15.47 | -63.28 | -11.45 | -16.59 | -1185.71 | -16.95 |
| EBITDA | -7.82 Million | -10.86 Million | -9.98 Million | - | -8.93 Million | -9.64 Million |
| Earnings Before Tax Margin | -16.03 | -65.83 | -12.11 | -17.85 | -1276.00 | -18.30 |
000027
CEYE
600666
SHARPINV
GRA
036710